Clinical Trial Update: Compare Technegas Ventilation-Perfusion SPECT and Xenon Ventilation-Perfusion Planar Imaging for Pulmonary Embolism [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Technegas ventilation-perfusion SPECT with Xenon ventilation-perfusion planar imaging for pulmonary embolism; the study was terminated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism

Drugs mentioned

• Technegas (Kit for the preparation of technetium Tc-99m-labeled carbon inhalation aerosol)
• Xenon-133 gas (xenon-133 gas)

Snippet

Sponsor: Cyclomedica Australia PTY Limited | Conditions: Pulmonary Embolism | Phase 3 | Status: TERMINATED | Results posted: 2015-11-10